Lead Provider- Integrated Health and Well-being Support for Adults, "The Hub", Central Halifax, Calderdale

  • The Borough Council of Calderdale

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-014046

Procurement identifier (OCID): ocds-h6vhtk-0455d1

Published 1 May 2024, 1:04pm



Section one: Contracting authority/entity

one.1) Name and addresses

The Borough Council of Calderdale

Town Hall, Crossley Street

Halifax

HX1 1UJ

Email

procurement@calderdale.gov.uk

Country

United Kingdom

Region code

UKE44 - Calderdale and Kirklees

National registration number

184 3147 61

Internet address(es)

Main address

https://www.calderdale.gov.uk/v2

Buyer's address

https://yortender.eu-supply.com/ctm/Company/CompanyInformation/Index/103251


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Lead Provider- Integrated Health and Well-being Support for Adults, "The Hub", Central Halifax, Calderdale

Reference number

86907

two.1.2) Main CPV code

  • 85323000 - Community health services

two.1.3) Type of contract

Services

two.1.4) Short description

The Borough Council of Calderdale is intending to follow the Most Suitable Provider Process to award this contract. The Contract is to lead seamless provision of Integrated Health and Well-being support for adults (IHWBS4A) in Central Halifax, Calderdale across organisations to improve outcomes for people. *see service specification for further detail.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-013759


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

II.2.4

Instead of
Text

Contract period: 1st April 2024 to 31st March 2027 with the option to extend on an annual basis, up until 31st March 2029 (3+1+1).

Read
Text

Contract period: The contract start date is as soon as the procurement process is complete, which is anticipated as approximately from July 2024, but will depend on agreement with the successful provider, and will thereafter run for 3 years with the option to extend on an annual basis, up until 31st March 2029 (3+1+1).